沃华医药
(002107)
| 流通市值：28.65亿 | | | 总市值：29.03亿 |
| 流通股本：5.70亿 | | | 总股本：5.77亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 576,678,675.17 | 395,153,676.21 | 215,317,031.37 | 909,506,771.72 |
| 营业收入 | 576,678,675.17 | 395,153,676.21 | 215,317,031.37 | 909,506,771.72 |
| 二、营业总成本 | 554,004,849.28 | 382,920,601.38 | 207,089,550.94 | 857,005,532.26 |
| 营业成本 | 159,899,955.56 | 109,791,991.38 | 58,313,333.5 | 232,437,403.26 |
| 税金及附加 | 9,553,006.4 | 6,291,725.27 | 3,303,074.04 | 15,192,060.57 |
| 销售费用 | 302,748,648.37 | 207,827,860.85 | 117,646,212.28 | 491,771,935.18 |
| 管理费用 | 56,290,696.75 | 41,332,829.13 | 20,923,085.12 | 77,348,443.63 |
| 研发费用 | 29,383,363.35 | 20,635,069.01 | 8,520,639.75 | 45,354,777.71 |
| 财务费用 | -3,870,821.15 | -2,958,874.26 | -1,616,793.75 | -5,099,088.09 |
| 其中:利息费用 | 5,816.5 | 5,669.51 | 3,831.38 | 35,435.28 |
| 其中:利息收入 | 3,915,939.43 | 2,986,818.99 | 1,632,212.28 | 5,227,891.79 |
| 资产减值损失(新) | -867,044.08 | -936,314.04 | -119,525.8 | -2,307,917.72 |
| 信用减值损失(新) | 679,741.77 | 762,050.98 | 760,379.8 | 1,235,548.09 |
| 其他收益 | 3,948,480.19 | 2,714,244.83 | 1,784,119.95 | 5,061,001.75 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 26,435,003.77 | 14,773,056.6 | 10,652,454.38 | 56,489,871.58 |
| 加:营业外收入 | 262,236.31 | 299,290.68 | 252,268.58 | 1,040,871.09 |
| 减:营业外支出 | 1,526,085.17 | 1,124,823.03 | 131,694.28 | 2,892,573.53 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 25,171,154.91 | 13,947,524.25 | 10,773,028.68 | 54,638,169.14 |
| 减:所得税费用 | 5,031,960.61 | 4,328,763.33 | 2,009,579.63 | 8,010,616.94 |
| 六、净利润 | 20,139,194.3 | 9,618,760.92 | 8,763,449.05 | 46,627,552.2 |
| 持续经营净利润 | 20,139,194.3 | 9,618,760.92 | 8,763,449.05 | 46,627,552.2 |
| 归属于母公司股东的净利润 | 22,909,628.29 | 11,081,494.83 | 9,667,223.23 | 58,767,086.78 |
| 少数股东损益 | -2,770,433.99 | -1,462,733.91 | -903,774.18 | -12,139,534.58 |
| (一)基本每股收益 | 0.04 | 0.02 | 0.02 | 0.1 |
| (二)稀释每股收益 | 0.04 | 0.02 | 0.02 | 0.1 |
| 九、综合收益总额 | 20,139,194.3 | 9,618,760.92 | 8,763,449.05 | 46,627,552.2 |
| 归属于母公司股东的综合收益总额 | 22,909,628.29 | 11,081,494.83 | 9,667,223.23 | 58,767,086.78 |
| 归属于少数股东的综合收益总额 | -2,770,433.99 | -1,462,733.91 | -903,774.18 | -12,139,534.58 |
| 公告日期 | 2024-10-26 | 2024-08-03 | 2024-04-27 | 2024-03-30 |
| 审计意见(境内) | | | | 标准无保留意见 |